GeoVax Labs, Inc. (GOVX-OTC) Nominated for Buzz of BIO Contest - Please VOTE!!

November 2018 Update Issued on GeoVax Labs (GOVX-OTC)

GeoVax Labs, Inc. (GOVX-OTC) Announces Publication of HIV Vaccines Review

CVR Medical Corp.: Company Update (CVM-TSX; CRRVF-OTCQB)

GeoVax Labs, Inc. (GOVX-OTC) Reports Vaccine Development Progress

CVR Medical Enlists JD Lymon Group to Provide Reimbursement & Study Design Support

August 2018 Update Issued on GeoVax Labs, Inc. (GOVX-OTC)

New Research Released on CVR Medical Corp. (CVM-TSX; CRRVF-OTCQB)

New Research Released on Precision Therapeutics Inc. (AIPT-NASDAQ)

March 2018 Update Issued on GeoVax Labs, Inc. (GOVX-OTC)

Aeterna Zentaris’ Marketing Authorization Application for Macrilen™ (macimorelin) for Evaluation of Adult Growth Hormone Deficiency Accepted by European Medicines Agency

New Research Released on ZapGo Ltd (closely held)

October 2017 Update Issued on GeoVax Labs, Inc. (GOVX-OTC)

NDA for Aeterna Zentaris' (AEZS) Macrilen™ Granted December 30, 2017 PDUFA Date

GeoVax Labs. (GOVX-OTC) Reports Promising Results for Lassa Fever Vaccine

New Research Released on GeoVax Labs, Inc. (GOVX-OTC)

May 2017 Update Released on Aeterna Zentaris (AEZS)

April 2017 Update Released on Aeterna Zentaris (AEZS)

New Research Released on Avivagen Inc. (VIV-TSX.V)

February 2017 Update Released on Aeterna Zentaris (AEZS)

MagneGas Signs Definitive Agreements for $2.65 Million Equipment Sale to German Company

Sir Gregory Winter Appointed as Interim Chair of Biosceptre Int'l

New Research Released on Hemispherx Biopharma $HEB

New Research Released on Ceapro Inc. $CZO

New Research Released on MagneGas Corp. $MNGA

September 2016 Update Released on Aeterna Zentaris (AEZS)

UPDATE: Four Recent Milestones for Diagnostics Company SpectraScience (SCIE)

Two New Slide Presentations: Ra Medical Systems and Biosceptre International

New Research Released on Ra Medical Systems, Inc.

New Research Released on Biosceptre Int'l Ltd.

Crystal Research Associates Featured by Small Cap Nation (Video)

ASCO and IMS Health: Trends in the Cancer Care Market

First Quarter 2016 Update on Catasys, Inc.

First Quarter 2016 Update on Aeterna Zentaris

Changes in the Mental Health Industry are Benefiting Patients, Providers, Insurers, and Investors

NEW RESEARCH: Quarterly Update Released on Aeterna Zentaris (AEZS)

Saleen Brand Opens First Showroom in China

Making the Most of Your Investor Presentation

New Research Released on Aperion Biologics, Inc.

Mega Mergers in Big Pharma: What's driving them?

Big Data Helping to Reinvent Healthcare

Positive Phase 2 Data in Prostate Cancer from Biopharma Company Aeterna Zentaris

New Slide Deck Available on Catasys, Inc.

New Research Released on Catasys, Inc. (CATS-OTC)

NEW RESEARCH: 48-page Report Available on Diagnostics Company SpectraScience (SCIE)

NEW RESEARCH: 12-page Quarterly Update on Aeterna Zentaris (AEZS-NASDAQ)

Journal of Drugs in Dermatology Publishes Phase 2 Data for New Acne Treatment

New Slide Deck Available on Specialty Biopharma Company, Aeterna Zentaris Inc.

Slide Deck Available on Clean Energy Company, Juhl Energy, Inc.

60-page Report on Newly Public Company XBiotech Inc. (XBIT-NASDAQ)

Aeterna Zentaris Finalizes Key Promotional Agreement with Merck’s EMD Serono, Inc.

Amarantus Receives Notice of Allowance for Patent Application on MANF

NEW RESEARCH: 52-page Report Available on Aeterna Zentaris Inc. (AEZS-NASDAQ)

NEW RESEARCH: 56-page Executive Informational Overview Released on Juhl Energy, Inc.

Boston Therapeutics Announces Q4 and FY 2014 Financial Results and Corporate Update

Boston Therapeutics Expands Sugardown® License to Japan; Chinese Trial to Start

Amarantus BioScience Publishes Positive Parkinson's Phase 2a Data in Brain Journal

Pressure BioSciences Announces First Sale of Barozyme™ HT48 and Accelerated Marketing

Boston Therapeutics Measures the Impact of sugardown® Taken Before Sodas

Amarantus Acquires Specialized Neuro-Diagnostics Company, DioGenix, Inc.

New Topical Cannabis Cream, TopiCanna, Hits the Market

New Video Clip: Jeff Kraws Talks Antibiotic Resistance Forecasts and Impacts

Chewable Pill to Help Treat Type 2 Diabetes Receives IND Approval

NEW RESEARCH: Quarterly Update Available on Truett-Hurst (THST)

Amarantus Announces Major Potential Acquisition and 2014 LymPro Test® Launch

Pressure BioSciences Reports a YTD Sales Increase of 45%

New Study Measures Impact of OTC Supplement to Reduce Glucose and Insulin After Drinking Soda

Saleen Preps for 2015 Mustang; Reports Q2 Financials

California Winemaker Truett-Hurst Reports 20% Increase in Sales for Q1 FY2015

Biotech Company Amarantus Provides Business Update/Q3 2014 Financial Results

Boston Therapeutics Announces North American Branding of sugardown®

17 Awards in 2014 (so far!) for Winemaker Truett-Hurst

New Method to Improve Drug Discovery and Design Hinges on PCT

Pressure BioSciences Partners With Powertech for Chinese Sales

The Market May Be Down, But Amarantus is Up on Its News

Senior Analyst & CEO Jeff Kraws Discusses Ebola Therapies and Vaccines

Study Data: Amarantus One Step Closer to a Q4 Launch of an Alzheimer's Blood Test

CardioComm Solutions (EKG) Becomes Approved Vendor to U.S. Government

WABC-TV (New York) Spotlights MetaStat's Technology in 30-Minute Special

Expanding Boston Therapeutics' Medical Advisory Board and Patentable Uses of BTI-320

Boston Therapeutics Ramps Up Sugardown®, Expands Board of Directors

CardioComm Solutions' Technology Tapped for Stroke Prevention Trial

NEW RESEARCH: Pressure BioSciences On the Move

At 1:00 PM ET TODAY, Truett-Hurst call and webcast for fiscal 2014 results

Boston Therapeutics Strengthens its Medical Advisory Board

Truett-Hurst to Launch Single-Serving Wine Beverages Through Kroger

Saleen Takes Orders for New 2015 Mustang (pictures & specs)

Boston Therapeutics Signs Agreement for Phase III Study of BTI-320

Total Wine & More Adding More Truett-Hurst Wines to Shelves

Amarantus BioScience Outlines Required Steps for Eltoprazine Trial

Clinical Trial Finds Link Between Xanax, Valium and Alzheimer's Disease

NEW RESEARCH: Amarantus Pursues Novel Blood Test for Alzheimer's and More

NEW RESEARCH: August 2014 Update on Boston Therapeutics (BTHE)

NEW Slide Presentation Released for Truett-Hurst, Inc. (THST-NASDAQ)

NEW RESEARCH: Truett-Hurst (THST-NASDAQ) Innovates the Wine Industry

Dial-in Info for Investor Conference Call with Pressure BioSciences, Inc. ($PBIO)

Are Speed and Performance the Future of Electric Vehicles? They are for Steve Saleen.

Pressure BioSciences (PBIO) to Consider Strategic Financing and Spin-off Options

NEW RESEARCH: 12-page Quarterly Update Available on Pressure BioSciences (PBIO)

NEW RESEARCH: Saleen Automotive Poised for Growth

NEW RESEARCH: 12-page Quarterly Update on Boston Therapeutics ($BTHE)

Boston Therapeutics $BTHE Announces Strategic Marketing Agreement for SUGARDOWN®

Boston Therapeutics (BTHE-OTC) Inks Agreement with Patheon for BTI-320

CEO Jeffrey Kraws Live Interview on Pharma M&A Activity with ARISE News

BTI320 Product Update from Boston Therapeutics, Inc. (BTHE-OTC)

NEW RESEARCH: Executive Informational Overview Released for MetaStat, Inc. (MTST-OTC)

Pressure BioSciences, Inc. (PBIO) Reports Fourth Quarter and Fiscal Year 2013 Financial Results

NEW RESEARCH: 60-Page Executive Informational Overview on Boston Therapeutics (BTHE) Just Added

Dial-in Info for Investor Conference Call with International Stem Cell ($ISCO)

CardioComm Solutions ($EKG) Receives Another Key FDA Medical Device Clearance

An Introduction to the Sample Preparation Life Science Research Market

NEW RESEARCH: Updated Executive Informational Overview for AtheroNova Inc. (AHRO)

New Video Available: Regenerative Medicine Panel at OneMedForum SF 2014

Regenerative Medicine "Extending Life and Limb" Workshop

We have an app and a brand new website!

NEW Quarterly Update Available for CardioComm Solutions (EKG-TSX.V)

Letter to Shareholders Details CardioComm Solutions' 2014 Milestones

ISCO Receives Award for its Metabolic Liver Disease Program

PBIO: Investor Call with Merriman Capital on Thurs., Dec. 12 at 4:30p

ISCO Announces Major Advance in iPS Stem Cell Technology

AtheroNova Announces Phase I Enrollment Complete for Clinical Trial of AHRO-001

AtheroNova Announces Phase I Enrollment Complete for Clinical Trial of AHRO-001 in Treating Atherosclerosis

Local Corp.: Core IP and Growing Markets Could Mean Business

Record Revenue and More Products to Come from Pressure BioSciences

ISCO: Third Quarter 2013 Financials and Business Update

Crystal Research CEO Speaks With ABC News/Al Jazeera on JNJ Settlement

NEW RESEARCH: Innovations in Life Science Research with $PBIO

Trio Resources (TRII) Begins Automating Mineral Processing

T3 Motion Creates National Service Program for its Electric Vehicles

Neonode (NEON): Next-Gen Chip Release and New Markets Fuel Growth

CardioComm’s HeartCheck™ Proven Valuable in Large-Scale Study

ISCO: New Preclinical Data, Continued Progress for Parkinson's Program

AtheroNova Announces New Member of Clinical Advisory Board

"The Smart Money is Heading Outside the U.S." - CNBC

Is Pharma Forecasting No Longer to be Trusted? McKinsey & Co. says Yes.

LRAD's Acoustic Hailing Devices to Aid in N. Colorado Flood Relief Efforts

NEW RESEARCH: 12-page Quarterly Update on International Stem Cell

ISCO Teams Up with Duke for Clinical Research in Parkinson's Disease

CardioComm Partner to Promote Case Study on SMART Monitoring Services

FULL VIDEO (Reuters TV): Biotech Stocks To Watch and More

Jeff Kraws Talks Opportunities for Biotech Investors

Home is where the HeartCheck™ is: NEW RESEARCH on CardioComm Solutions

NEW RESEARCH: 72-page Report on International Stem Cell Corp. (ISCO)

Russian Biotech Sector is Good News for U.S. Companies

AtheroNova Initiates Phase I Trial of AHRO-001

Fund Managers Unplugged: Industry Veterans Predict Stock Performance

NEW RESEARCH: 52-page Report on Convoy Therapeutics, Inc.

Join us at the 4th Annual OneMedForum 2013 in New York: June 26-27

AtheroNova Reaches Major Milestone: Starts Phase I in June

Crystal Research Enters into Strategic Partnership with MZ Group

NEW RESEARCH: 60-page Report on Trio Resources, Inc. (TRII-OTC)

Earnings Season Highlights: LRAD Corp. (LRAD-NASDAQ)

Earnings Season Highlights: Neonode Inc. (NEON-NASDAQ)

MetaStat Focuses on Lead Product Opportunity and Bolstering Pipeline

AHRO Nears its Phase I Start with Appointment of Clinical Chair

April 2013 Quarterly Update and Business Review on AtheroNova (AHRO)

CEO Jeff Kraws Featured on Reuters' State of the Union Roundtable

NEW RESEARCH: Quarterly Update on AtheroNova Inc.

NEW INDUSTRY REPORT: Guide for Investing in Green Infrastructure

NEW RESEARCH: New Year, Expanding Markets for LRAD Corp.

New Research: Report on MetaStat, Inc. (MTST-OTC.BB)

Today, January 9, 2013 at 4 PM: "Fund Managers Unplugged"

"Special Session: Fund Managers Unplugged" at OneMedForum SF 2013

Happy Holidays from Crystal Research Associates

QUARTERLY UPDATE: AtheroNova (AHRO-OTC) Prepares for Phase I Trials

Crystal Research Associates to Sponsor 6th Annual OneMedForum

AtheroNova Completes $2.9 Million Private Placement of Common Stock

New Nano Research: August 2012 Update Now Publicly Available

NEW REPORT: Quarterly Update on Neonode Inc. (NEON-NASDAQ)

EU: Finding a Regulatory Pathway for Nanomaterials

NEW REPORT: Quarterly Update on LRAD (NASDAQ)

Top Nanotech Innovators of 2012

Look for Neonode's Technology in the New Sony Reader PRS-T2 eReader

New Research Available on Local Corporation (LOCM-NASDAQ)

July 2012 Update to "Nanotechnology and the Built Environment" Available

LEED-Certified Green Buildings Have an Expanding Global Footprint

Can you hear me now? Key News Reports from LRAD Corp. (LRAD-NASDAQ)

Monday's Small-cap Movers under Crystal Research's Coverage

GenSpera Receives FDA Clearance to Initiate Phase II Clinical Trials in Prostate Cancer

Syringe company Unilife Corp. (UNIS-NASDAQ) reports higher 4Q revenues

2Q Cleantech Investments of $1.6 billion Target Resource Efficiency

QUARTERLY UPDATE: AtheroNova (AHRO-OTC) Receives Key Patent Allowance

"Devices hurt by Obamacare, hospitals win: Kraws" (Replay and Transcript)

CEO Jeff Kraws Weighs In on Obamacare Ruling: Stocks to Watch on Reuters Live Video

Second Quarter FY2012 Financial Results and Business Update on LRAD Corp. (LRAD-NASDAQ)

NEW RESEARCH: AtheroNova (AHRO-OTC) Works to Unclog Your Arteries

Protect Yourself From Exposed Sharps With MedPro Safety Products

"Beyond Wall Street's Panama Canal" Makes Case for Independent Research

LRAD Corp.'s Acoustic Technology To Be Used at 2012 NATO Summit

BELLUS Health Reports 1Q Financial Results, Provides Corporate Update

LRAD Corp. Receives $1.7 Million LRAD-RX Order for Asian Maritime Security

Sustainable Technologies Gain Momentum: New Report Highlights News

Crystal Research CEO Jeffrey Kraws Appointed Chairman of the Board, Synthetic Biologics (SYN-NYSE Amex)

MedPro and Unilife Featured in Drug Development & Delivery Magazine

Israeli Government Awards T3 Motion 2-Year Electric Vehicle Contract

NEW REPORT on Document Capture Technologies (DCMT)

Jeff Kraws Weighs In on Supreme Court Victory for Generic Drug Makers

NEW REPORT: Recent Developments in Nanotechnology You Need to Know

Unilife Corp. (UNIS): There's a new app for that

Neonode (NEON-OTC.BB) is Changing Your Touchscreen

APDN's Revenues Rise 63% in the First Quarter FY 2012

Authentidate Holding Corp. (ADAT) Second Quarter FY 2012 Update

Independent Equity Research Report on T3 Motion, Inc. (TTTM)

Independent Equity Research Report on LRAD Corp. (LRAD-NASDAQ)

APDN's Technology Could Prevent Cheating on Standardized Tests

TapImmune's New State-of-the-Art Lab Facilities and Office Space

APDN Uses Nanotechnology to Prevent Counterfeit Computer Chips

Healthcare Conferences and News: Week of 1/9 to 1/13

Corporate Milestone Update for GenSpera (GNSZ)

Exploring Rare Earth Elements to Meet Worldwide Demand

Nanotechnology & the Built Environment

APDN’s Anti-Counterfeiting Technology Addresses New Federal Legislation

CEL-SCI Continues Advancing to the Start of Phase III Trials for Multikine

Advances in Alzheimer’s Research Fuels the Development of Possible Treatments

New Research Available on Adamis Pharmaceuticals Corp. (ADMP-OTC)

Quarterly Update Available on Document Capture Technologies (DCMT-OTC)

First Quarter 2011 Financial Summary and Business Update Published on BELLUS Health

New Research Available on MedeFile International Inc. (MDFI-OTC)

University of Texas Selects WordLogic Text Entry System for Texas Technology Access Program

Quarterly Update Issued on GenSpera, Inc.

Dell Inc. Signs Reseller Agreement with WordLogic Corp. and other news

Quarterly Update Issued on Applied DNA Sciences, Inc.

New Research Issued on General Cannabis, Inc. (CANA-OTC)

New Research Available: Document Capture Technologies, Inc.

New research available on WordLogic Corp. (WLGC-OTC)

M&A activity on the rise for 2011

New research available on Bioniche Life Sciences

Recent Financial Results and Updates

Large Pharma Increasing Investment in Emerging Countries

Unilife to report 2Q FY 2011 financial results in the U.S. on Feb. 14

Updated business outlook available on Peregrine Pharmaceuticals

New Research Issued on Laep Investments Ltd.

Out with the old and in with the new…

A Solid Start to 2011

Both Sides of the Fence for 2011

New Research Released on BELLUS Health Inc.

Mid-Week News Highlights (12/6-12/8) from CRA’s Coverage Universe

Updated Executive Informational Overview Released on Authentidate Holding Corp.

Unilife Reports Financial Results and Significant Milestones

Up to $1 Billion in New Credits/Grants for Healthcare

Recent Financial Results and Corporate Updates

New research available on Applied DNA Sciences

Bioniche Named Among Top Employers in Canada

New research available at www.crystalra.com

Promising Clinical Events from Neuralstem and Peregrine

Corporate Update from TapImmune and Positive Phase II Data from ACT Biotech

CEL-SCI’s progress toward the start of its Phase III trial

News from Generex, Pluristem, and Vena

Your unbiased source for under-the-radar investing ideas.

Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Topic